Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kahofer

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Pediatric Dermatology|June 6, 2003
Dystrophic epidermolysis bullosa inversa with COL7A1 mutations and absence of GDA-J/F3 proteinPeter Kahofer, Leena Bruckner-Tuderman, Dieter Metze, et al.
Journal of the American Academy of Dermatology|November 4, 2004
Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVAFranz J Legat, Angelika Hofer, Franz Quehenberger, et al.
European Journal of Dermatology : EJD|April 16, 2003
Pseudolymphoma occurring in a tattooPeter Kahofer, Laila El Shabrawi-Caelen, Michael Horn, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Pediatric Dermatology|June 6, 2003
Dystrophic epidermolysis bullosa inversa with COL7A1 mutations and absence of GDA-J/F3 proteinPeter Kahofer, Leena Bruckner-Tuderman, Dieter Metze, et al.
Journal of the American Academy of Dermatology|November 4, 2004
Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVAFranz J Legat, Angelika Hofer, Franz Quehenberger, et al.
European Journal of Dermatology : EJD|April 16, 2003
Pseudolymphoma occurring in a tattooPeter Kahofer, Laila El Shabrawi-Caelen, Michael Horn, et al.
Pageof 1